DUBAI, UAE, Jan. 10, 2025 /PRNewswire/ — StockGro, India’s leading platform for experiential financial education, has joined hands with the Global Indian…
LAVA-1266 is a potent and selective bispecific anti-CD123 Gammabody® First-in-human study enrolling adult patients with CD123-expressing AML or MDS Initial…